Trastuzumab emtansine
About
Therapy type: Targeted therapy
Therapy strategy: HER2 inhibition
Mappings
NCI Thesaurus: Trastuzumab Emtansine (ncit:C82492)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | HER2-positive | Invasive Breast Carcinoma | Trastuzumab emtansine | |
| Sensitivity (+) | HER2-positive | Invasive Breast Carcinoma | Trastuzumab emtansine | |
| Sensitivity (+) | HER2-positive | Invasive Breast Carcinoma | Trastuzumab emtansine | |
| Sensitivity (+) | ERBB2 amplification | Invasive Breast Carcinoma | Trastuzumab emtansine | |
| Sensitivity (+) | HER2-positive | Invasive Breast Carcinoma | Trastuzumab emtansine | |
| Sensitivity (+) | ERBB2 amplification | Invasive Breast Carcinoma | Trastuzumab emtansine | |
| Sensitivity (+) | HER2-positive | Invasive Breast Carcinoma | Trastuzumab emtansine | |
| Sensitivity (+) | HER2-positive | Invasive Breast Carcinoma | Trastuzumab emtansine |